retatrutide trial news today Retatrutide, a new weight loss drug not available on the market yet, is showing promising results in trials. @DrLaPook explains it’s doing much more than what current medications can Retatrutide: FDA approval time, trial

Patients who need long-term weight management support

Researchers noticed a significant improvement in numerous age-related phenotypes, such as restored fitness and physical activity levels, better fur quality in density, as well as higher quality kidney function markers

When cytoplasmic concentrations of neurotransmitters rise dangerously high, TAAR1 activates G-protein-dependent signaling pathways that recruit intracellular kinases, including protein kinase C (PKC) and calcium/calmodulin-dependent protein kinase II (CaMKII) (Underhill et al., 2020)

10.3390/ijms25137191 34 GaoB.LuY.LaiX.XuX.GouS.YangZ.et al (2025)